Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Schedule of basic and diluted net loss per share

Basic and diluted net loss per share attributable to common shareholders of Biohaven was calculated as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Numerator:
Net loss	$	(319,771)	$	(90,346)	$	(499,275)	$	(160,838)
Denominator:
Weighted average common shares outstanding—basic and diluted	87,766,069		68,248,023		84,174,099		68,227,564
Net loss per share — basic and diluted	$	(3.64)	$	(1.32)	$	(5.93)	$	(2.36)

Schedule of potentially anti-dilutive securities excluded from calculation of diluted net loss per share

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:

	As of June 30,
	2024	2023
Options to purchase common shares	13,545,016	9,639,557
Warrants to purchase common shares	294,195	—
Restricted share units	263,672	—
Total	14,102,883	9,639,557